Bryan Charleston

microbiologist

Born 1959-05-07

Bryan Charleston is …
instance of (P31):
humanQ5

External links are
P496ORCID iD0000-0002-6952-9338
P4789Who's Who UK IDU290044

P512academic degreeDoctor of PhilosophyQ752297
P166award receivedFellow of the Royal SocietyQ15631401
P108employerPirbright InstituteQ6039151
P735given nameBryanQ3894860
BryanQ3894860
P106occupationresearcherQ1650915
microbiologistQ3779582
P21sex or gendermaleQ6581097

Reverse relations

author (P50)
Q71566470A novel uterine protein that associates with the embryonic capsule in equids
Q40190560A replication-competent foot-and-mouth disease virus expressing a luciferase reporter.
Q39542454Accumulation of nucleotide substitutions occurring during experimental transmission of foot-and-mouth disease virus.
Q30388110Aerosol Delivery of a Candidate Universal Influenza Vaccine Reduces Viral Load in Pigs Challenged with Pandemic H1N1 Virus.
Q27472937Alpha/beta and gamma interferons are induced by infection with noncytopathic bovine viral diarrhea virus in vivo.
Q45397140An MHC-restricted CD8+ T-cell response is induced in cattle by foot-and-mouth disease virus (FMDV) infection and also following vaccination with inactivated FMDV.
Q36673744An interferon-induced Mx protein: cDNA sequence and high-level expression in the endometrium of pregnant sheep.
Q42678559Analysis of the repertoire of cattle CD4(+) T cells reactive with bovine viral diarrhoea virus.
Q38784217Application of the thermofluor PaSTRy technique for improving foot-and-mouth disease virus vaccine formulation.
Q35576469Aspects of the innate and adaptive immune responses to acute infections with BVDV
Q36367906Assessment of T-dependent and T-independent immune responses in cattle using a B cell ELISPOT assay
Q81288321Assessment of the efficacy of tilmicosin as a treatment for Mycoplasma gallisepticum infections in chickens
Q41154969Assessment of the enhancement of PLGA nanoparticle uptake by dendritic cells through the addition of natural receptor ligands and monoclonal antibody
Q27478375Bovine Viral Diarrhea Virus: Prevention of Persistent Fetal Infection by a Combination of Two Mutations Affecting Erns RNase and Npro Protease
Q35076844Bovine plasmacytoid dendritic cells are the major source of type I interferon in response to foot-and-mouth disease virus in vitro and in vivo.
Q43000630Bovine viral diarrhoea virus: its effects on ovarian function in the cow.
Q40963680Bovine γδ T cells are a major regulatory T cell subset.
Q42699658CD4+ T-cell responses to foot-and-mouth disease virus in vaccinated cattle.
Q38936078Cattle remain immunocompetent during the acute phase of foot-and-mouth disease virus infection.
Q42666963Characterization of epitope-tagged foot-and-mouth disease virus
Q58747407Chimeric O1K foot-and-mouth disease virus with SAT2 outer capsid as an FMD vaccine candidate
Q36548980Chimpanzee Adenovirus Vaccine Provides Multispecies Protection against Rift Valley Fever
Q39855667Clinical and laboratory investigations of the outbreaks of foot-and-mouth disease in southern England in 2007.
Q54226450Comparison of Heterosubtypic Protection in Ferrets and Pigs Induced by a Single-Cycle Influenza Vaccine.
Q93503777Comparison of the efficacies of three fluoroquinolone antimicrobial agents, given as continuous or pulsed-water medication, against Escherichia coli infection in chickens
Q47548484Detection of Pathogen Exposure in African Buffalo Using Non-Specific Markers of Inflammation
Q34057878Determining the epitope dominance on the capsid of a serotype SAT2 foot-and-mouth disease virus by mutational analyses.
Q36878914Differential Persistence of Foot-and-Mouth Disease Virus in African Buffalo Is Related to Virus Virulence.
Q35192675Differential effects of viral vectors on migratory afferent lymph dendritic cells in vitro predict enhanced immunogenicity in vivo.
Q30394336Distinct immune responses and virus shedding in pigs following aerosol, intra-nasal and contact infection with pandemic swine influenza A virus, A(H1N1)09
Q36572854Efficient production of foot-and-mouth disease virus empty capsids in insect cells following down regulation of 3C protease activity
Q43032855Establishment of persistent infection with non-cytopathic bovine viral diarrhoea virus in cattle is associated with a failure to induce type I interferon.
Q37866385Evidence of activation and suppression during the early immune response to foot-and-mouth disease virus.
Q40343205Experimental acute infection of alpacas with Bovine viral diarrhea virus 1 subgenotype b alters peripheral blood and GALT leukocyte subsets
Q40123532Fibrinogen is localized on dark zone follicular dendritic cells in vivo and enhances the proliferation and survival of a centroblastic cell line in vitro.
Q43153250Foot-and-mouth disease virus can induce a specific and rapid CD4+ T-cell-independent neutralizing and isotype class-switched antibody response in naïve cattle.
Q34741667Foot-and-mouth disease virus exhibits an altered tropism in the presence of specific immunoglobulins, enabling productive infection and killing of dendritic cells.
Q27438168Foot-and-mouth disease virus persists in the light zone of germinal centres
Q39034584Frequency and phenotype of natural killer cells and natural killer cell subsets in bovine lymphoid compartments and blood.
Q87360246GUEST EDITORIAL - The importance of sound experimental design and analysis
Q42999007Germinal centre localization of bovine viral diarrhoea virus in persistently infected animals.
Q36663758Global FMD control--is it an option?
Q38869889Global Foot-and-Mouth Disease Research Update and Gap Analysis: 1 - Overview of Global Status and Research Needs
Q38851221Global Foot-and-Mouth Disease Research Update and Gap Analysis: 2 - Epidemiology, Wildlife and Economics.
Q38851217Global Foot-and-Mouth Disease Research Update and Gap Analysis: 3 - Vaccines
Q38851213Global Foot-and-Mouth Disease Research Update and Gap Analysis: 4 - Diagnostics.
Q38851209Global Foot-and-Mouth Disease Research Update and Gap Analysis: 5 - Biotherapeutics and Disinfectants
Q38851205Global Foot-and-Mouth Disease Research Update and Gap Analysis: 6 - Immunology
Q38851202Global Foot-and-Mouth Disease Research Update and Gap Analysis: 7 - Pathogenesis and Molecular Biology.
Q34738862Hsp110-mediated enhancement of CD4+ T cell responses to the envelope glycoprotein of members of the family Flaviviridae in vitro does not occur in vivo
Q33701133Hsp70 enhances presentation of FMDV antigen to bovine CD4+ T cells in vitro.
Q36949946Identification of Salmonella enterica serovar Dublin-specific sequences by subtractive hybridization and analysis of their role in intestinal colonization and systemic translocation in cattle
Q27469811Identification of a cell population that produces alpha/beta interferon in vitro and in vivo in response to noncytopathic bovine viral diarrhea virus.
Q45403428Identification of a novel foot-and-mouth disease virus specific T-cell epitope with immunodominant characteristics in cattle with MHC serotype A31.
Q34199805Immune responses in pigs vaccinated with adjuvanted and non-adjuvanted A(H1N1)pdm/09 influenza vaccines used in human immunization programmes
Q42989301Immunohistochemical evidence for the localization of bovine viral diarrhea virus, a single-stranded RNA virus, in ovarian oocytes in the cow.
Q30429455Improved adjuvanting of seasonal influenza vaccines: preclinical studies of MVA-NP+M1 coadministration with inactivated influenza vaccine
Q42375439Induction of a cross-reactive CD8(+) T cell response following foot-and-mouth disease virus vaccination.
Q54109159Induction of influenza-specific local CD8 T-cells in the respiratory tract after aerosol delivery of vaccine antigen or virus in the Babraham inbred pig.
Q45024291Infection of cattle with Theileria parva induces an early CD8 T cell response lacking appropriate effector function.
Q59240960Influence of the nature of the antigen on the boosting of responses to mycobacteria in M. bovis-BCG vaccinated cattle
Q45423150Interferon-gamma production in vitro from whole blood of foot-and-mouth disease virus (FMDV) vaccinated and infected cattle after incubation with inactivated FMDV.
Q40061913Isolation of Single-Domain Antibody Fragments That Preferentially Detect Intact (146S) Particles of Foot-and-Mouth Disease Virus for Use in Vaccine Quality Control.
Q34366399Laboratory animal models to study foot-and-mouth disease: a review with emphasis on natural and vaccine-induced immunity
Q57098605Longevity of protection in cattle following immunisation with emergency FMD A22 serotype vaccine from the UK strategic reserve
Q44537139Massive, sustained gammadelta T cell migration from the bovine skin in vivo
Q95824285Massive, sustained γδ T cell migration from the bovine skin in vivo
Q47571977Migratory sub-populations of afferent lymphatic dendritic cells differ in their interactions with Mycobacterium bovis Bacille Calmette Guerin.
Q34170015Modelling the influence of foot-and-mouth disease vaccine antigen stability and dose on the bovine immune response.
Q45357184Modelling the within-host dynamics of the foot-and-mouth disease virus in cattle.
Q35943471Modified vaccinia virus Ankara-based vaccine vectors induce apoptosis in dendritic cells draining from the skin via both the extrinsic and intrinsic caspase pathways, preventing efficient antigen presentation.
Q43036793Modulation of sex hormone secretion in cows by acute infection with bovine viral diarrhoea virus.
Q35799818Mycobacterium bovis shedding patterns from experimentally infected calves and the effect of concurrent infection with bovine viral diarrhoea virus
Q36852321Potency of a thermostabilised chimpanzee adenovirus Rift Valley Fever vaccine in cattle
Q42991493Prolonged nasal shedding and viraemia of cytopathogenic bovine virus diarrhoea virus in experimental late-onset mucosal disease.
Q40380624Quantification of different human alpha interferon subtypes and pegylated interferon activities by measuring MxA promoter activation
Q27677139Rational Engineering of Recombinant Picornavirus Capsids to Produce Safe, Protective Vaccine Antigen
Q52650429Recent advances in veterinary applications of structural vaccinology.
Q74508110Regulation of MHC class I gene expression is at transcriptional and post-transcriptional level in bovine placenta
Q51571274Relationship between clinical signs and transmission of an infectious disease and the implications for control.
Q30854552Rules of engagement between αvβ6 integrin and foot-and-mouth disease virus
Q38744534SAT2 Foot-and-Mouth Disease Virus Structurally Modified for Increased Thermostability
Q90912985Safety and efficacy of ChAdOx1 RVF vaccine against Rift Valley fever in pregnant sheep and goats
Q27702186Structure-based energetics of protein interfaces guides foot-and-mouth disease virus vaccine design
Q33295285Systemic translocation of Salmonella enterica serovar Dublin in cattle occurs predominantly via efferent lymphatics in a cell-free niche and requires type III secretion system 1 (T3SS-1) but not T3SS-2
Q91658607Tackling human and animal health threats through innovative vaccinology in Africa
Q38947438The B Cell Response to Foot-and-Mouth Disease Virus in Cattle following Sequential Vaccination with Multiple Serotypes
Q38766380The B-cell response to foot-and-mouth-disease virus in cattle following vaccination and live-virus challenge.
Q52567742The MHC homozygous inbred Babraham pig as a resource for veterinary and translational medicine.
Q40065557The Npro product of classical swine fever virus and bovine viral diarrhea virus uses a conserved mechanism to target interferon regulatory factor-3.
Q33352440The Npro product of classical swine fever virus interacts with IkappaBalpha, the NF-kappaB inhibitor.
Q28115637The classical swine fever virus N-terminal protease N(pro) binds to cellular HAX-1
Q39775972The classical swine fever virus Npro product is degraded by cellular proteasomes in a manner that does not require interaction with interferon regulatory factor 3.
Q24320429The developmental regulation of a novel muscle LIM-protein
Q42040556The glycosylation pattern of baculovirus expressed envelope protein E2 affects its ability to prevent infection with bovine viral diarrhoea virus.
Q84203753The importance of FMDV localisation in lymphoid tissue
Q35091556The relative magnitude of transgene-specific adaptive immune responses induced by human and chimpanzee adenovirus vectors differs between laboratory animals and a target species
Q36177341The role of dendritic cells in shaping the immune response.
Q54217589Therapeutic Administration of Broadly Neutralizing FI6 Antibody Reveals Lack of Interaction Between Human IgG1 and Pig Fc Receptors.
Q40574579Transduction of skin-migrating dendritic cells by human adenovirus 5 occurs via an actin-dependent phagocytic pathway
Q38780088Type I and III IFNs Produced by Plasmacytoid Dendritic Cells in Response to a Member of the Flaviviridae Suppress Cellular Immune Responses.
Q38222524Type I and III interferon production in response to RNA viruses.
Q45365192Understanding foot-and-mouth disease virus early pathogenesis and immune responses.
Q37027760Understanding foot-and-mouth disease virus transmission biology: identification of the indicators of infectiousness.
Q58830787Universal detection of foot and mouth disease virus based on the conserved VP0 protein
Q74277605Use of colostrum from rotavirus-immunised cows as a single feed to prevent rotavirus-induced diarrhoea in calves

Search more.